Document is current
Any future updates will be listed below
-
Authors
- License Information
-
More Information
Article History
First Online: 29 April 2026
Competing interests
: H.M. and Y.H. declare no competing interests. D.G.A discloses competing interest due to past and present advising roles for Alnylam, Sanofi, Translate Bio, oRNA Therapeutics, CRISPR Therapeutics, Souffle Therapeutics and Combined Therapeutics.
